Thursday, May 2, 2013

Decreasing Infections from a Prostate Biopsy

In today's video from Dr. Gerald Chodak, he discusses the risks of infection from having a prostate biopsy and what measures can be taken to minimize those risks. 


Monday, April 29, 2013

Supplements don't help with prostate cancer

NEW YORK (Reuters Health) - 

Despite dietary supplements being popular among prostate cancer patients, a new review of past research says they are not effective treatments for the disease.
Pulling together data from eight randomized controlled trials - considered the gold standard of medical research, researchers found non-herbal dietary supplements and vitamins didn't significantly change the severity of people's cancers.


"The main message would be that no miraculous supplement for (prostate cancer) exists," wrote Dr. Paul Posadzki, the review's lead author from the Korea Institute of Oriental Medicine in Daejeon, in an email to Reuters Health.

Sickle cell disease accounts for many priapism cases



NEW YORK (Reuters Health) - Thanks to commercials for erectile dysfunction drugs, men know to seek medical attention for "erections lasting more than four hours," but a new study suggests a blood disorder is the cause of many prolonged erections.
While the condition - formally known as priapism - is rare, researchers report in The Journal of Urology that between 14 percent and 30 percent of cases that show up in U.S. emergency rooms are men with sickle-cell disease.
"I would say what the paper is telling us is that sickle-cell disease is still responsible for the bulk of the visits for priapism," said Dr. Gregory Broderick, professor of urology at the Mayo Clinic in Jacksonville, Florida, who was not involved in the study.


Prostate cancer screening for older men 'unlikely'

 NHS Choices (Wed April 17, 2013)

There is wide coverage of new research that argues that routine screening could reduce deaths from prostate cancer, with BBC News, The Daily Telegraph and the Daily Mail all reporting the story. This controversial study is likely to reignite the debate about whether routine screening for prostate cancer does more harm than good.

Read the full NHS report